RxDoctor Payments Data

Kishore Subnani, MD

Clinical Cardiac Electrophysiology · Little River, SCNPI 1013151653

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (52.1%), travel and lodging and education — rather than concentrated in one kind of arrangement. Biotronik Inc. accounts for 62.5% of it on its own, with 33 other manufacturers making up the rest. Reporting peaked in 2022 at $10,925 and has fallen 87.6% since, to $1,353 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in SC, where the typical reported total is $35,448.

$30,594in general payments, 2019–2025

Across 579 payments — averaging $52.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biotronik Inc.$19K
  • Abbott$3K
  • Boston Scientific$2K
  • Biosense Webster, Inc.$2K
  • Medical Device Business Services, Inc.$1K
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$473
  • plus $3K from 28 others
$2,801in research payments, 2019–2025

Across 7 payments — averaging $400.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$3K

What the payments were for

  • Travel & lodging$14,51647%
  • Food & beverage$15,94952%
  • Education$1280%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$30,594 in reported general payments places this provider in the 45th percentile of 58 clinical cardiac electrophysiology providers in South Carolina.

See all clinical cardiac electrophysiology providers in South Carolina

Medicare billing

Part B allowed, 2024
$505,704
Medicare patients
872
Services billed
5,077

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban219$253,026
MultaqDronedarone Hcl62$74,708
XareltoRivaroxaban36$32,207
FarxigaDapagliflozin Propanediol26$21,471
EntrestoSacubitril/Valsartan23$17,087
Dofetilide73$16,972
Flecainide Acetate79$3,653
Diltiazem 24hr Er (Cd)Diltiazem Hcl33$2,519
Metoprolol Succinate95$1,790
Mexiletine Hcl13$1,517
Diltiazem Hcl47$1,470
SotalolSotalol Hcl39$742
Metoprolol Tartrate69$592
Amiodarone Hcl24$450
Carvedilol45$437

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$206$253,026219 claims
Sanofi-aventis U.S. LLCMultaq$18$74,70862 claims
Johnson & JohnsonXarelto$409$32,20736 claims
AstraZenecaFarxiga$80$21,47126 claims
NovartisEntresto$109$17,08723 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 58 clinical cardiac electrophysiology providers in South Carolina.

Other clinical cardiac electrophysiology in Little River

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →